Skip to main content

Wright Denies Involvement In Profemur Hip Implant Failure

Wright Denies Involvement In Profemur Hip Implant Failure

Wright Denies Involvement In Profemur Hip Implant Failure

Introduction

In a response submitted on September 28, 2018, Wright Medical Technology Inc. denied allegations that their Profemur Z hip implant was defectively designed and the company knowingly concealed the health risks associated with the device.

The response filed in the District of Connecticut cited several affirmative defenses and stated that the claims mentioned in the lawsuit are preempted by federal law and also, barred by the learned intermediary doctrine. The case involved claims made by a plaintiff who underwent total hip replacement surgery on March 30, 2005, during which he was implanted with Wright's Profemur device. Wright hip implant multidistrict litigation (MDL 2329) which was created in February 2012, was shut down by U.S. District Judge William Duffey on June 22.

Zimmer Inc. and Stryker Corporation face similar allegations over their Hip implant products for causing internal complications due to the faulty design. Stryker Hip Replacement lawsuits are centralized before U.S. District Judge Indira Talwani under MDL No. 2768 – in Re: Stryker LFIT V40 Femoral Head Products Liability Litigation.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.